Neogen Launches Enhanced Genomic Test for Cats

LINCOLN, Neb., June 13, 2023 /PRNewswire/ — Neogen® Corporation (NASDAQ: NEOG) announced today that it has launched My CatScan™ 2.0, a significantly upgraded and improved version of the test from a leader in genetic screening for cats. With the addition of 39 new diseases and genetic…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.